Nachrichten zur Pixium Vision S.A. Aktie

Pixium Vision announces the rejection of the sale plan (plan de cession) by the Court and the conversion of the…

Pixium Vision announces the 48-Month Trial Results in Severe Atrophic AMD…

Pixium Vision announces the conversion of the safeguard proceedings into receivership…

Pixium Vision announces its financial results for H1 2023 and provides update …

Pixium Vision announces the launch of a process to find buyers…

Pixium Vision announces the opening of safeguard proceedings…

 …

Pixium Vision announces the implementation of a bridge financing with Bpifrance and Sofinnova and a reverse stock split on the…

Pixium Vision announces the agreement to extend the maturity date of the outstanding notes associated with the terminated ESGO financing…

Pixium Vision announces receipt of € 1.8 million from the French Government as Research Tax Credit...…

Pixium Vision convenes its Annual Meeting of Shareholders on June 13, 2023...…

        Pixium Vision announces the availability of itsannual report for the financial year 2022...…

        Pixium Vision announces its consolidated financial statements for the financial year 2022 and the consolidated cash balance for March 31,…

Pixium Vision announces FDA Breakthrough Device Designation for the Prima System in Dry AMD...…

Das Instrument PXH FR0011950641 PIXIUM VISION SA EO -,02 EQUITY wird ex Kapitalmassnahme gehandelt am 21.03.2023 The instrument PXH FR0011950641…

Pixium Vision announces termination of convertible note financing agreement with US-based healthcare investor ESGO...…

      Pixium Vision announces its cash position at...…

Pixium Vision convenes an Extraordinary General Meeting of Shareholders on February 15, 2023...…

Pixium Vision announces peer-reviewed publications demonstrating the potential of the Next Generation PRIMA implant to restore vision at five times…